How Targeted Cancer Drugs Disrupt the Cell Cycle
PLOS: DNA Science
JUNE 22, 2023
Throughout the cell cycle, cyclin and kinase proteins pair and part in ways that activate the genes whose products carry out mitosis. The candidate drug, vorasidenib, is a small molecule that inhibits survivin. She chronicled her journey in Glamour and in My So-Called Normal Life, a book published in 2005. Blood cancer.
52 
Let's personalize your content